d‐BRU - Dental Biomaterials Research Unit - ULiège [BE]
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
vettore, Nicola
Moray, Joël ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines
Brans, Alain ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines
Herman, Raphaël ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'Ingénierie des Protéines
Charlier, Paulette ; Université de Liège - ULiège > Département des sciences de la vie > Cristallographie des macromolécules biologiques
kumita, Janet
Kerff, Frédéric ; Université de Liège - ULiège > Département des sciences de la vie > Centre d'ingénierie des protéines
Dobson, Christopher
Dumoulin, Mireille ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Language :
English
Title :
Characterisation of the structural, dynamic and aggregation properties of the W64R amyloidogenic variant of human lysozyme
Dumoulin, M., Kumita, J.R., Dobson, C.M., Normal and aberrant biological self-assembly: insights from studies of human lysozyme and its amyloidogenic variants. Acc. Chem. Res., 2006, 10.1021/ar050070g.
Dumoulin, M., Familial amyloidosis caused by lysozyme. Protein Misfolding Dis. Curr. Emerg. Princ. Ther, 2010, 10.1002/9780470572702.ch39.
Valleix, S., Drunat, S., Philit, J.B., Adoue, D., Piette, J.C., Droz, D., Mac Gregor, B., Canet, D., Delpech, M., Grateau, G., Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int., 2002, 10.1046/j.1523-1755.2002.00205.x.
Girnius, S., Skinner, M., Spencer, B., Prokaeva, T., Bartholomew, C., O'Hara, C., Seldin, D.C., Connors, L.H., A new lysozyme tyr54asn mutation causing amyloidosis in a family of Swedish ancestry with gastrointestinal symptoms. Amyloid, 2012, 10.3109/13506129.2012.723074.
Li, Z., Xu, H., Liu, D., Li, D., Liu, G., Wang, S.X., Hereditary renal amyloidosis with a variant lysozyme p.Trp82Arg in a Chinese family: case report and literature review. BMC Nephrol., 20, 2019, 10.1186/s12882-019-1496-6.
Booth, D.R., Pepys, M.B., Hawkins, P.N., A novel variant of human lysozyme (T70N) is common in the normal population. Hum. Mutat., 2000, 10.1002/1098-1004(200008)16:2<180::aid-humu20>3.0.co;2-%23.
Röcken, C., Becker, K., Fändrich, M., Schroeckh, V., Stix, B., Rath, T., Kähne, T., Dierkes, J., Roessner, A., Albert, F.W., ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene. Hum. Mutat., 2006, 10.1002/humu.9393.
Artymiuk, P.J., Blake, C.C.F., Refinement of human lysozyme at 1.5 Å resolution analysis of non-bonded and hydrogen-bond interactions. J. Mol. Biol., 1981, 10.1016/0022-2836(81)90125-X.
Moura, A., Nocerino, P., Gilbertson, J.A., Rendell, N.B., Mangione, P.P., Verona, G., Rowczenio, D., Gillmore, J.D., Taylor, G.W., Bellotti, V., Canetti, D., Lysozyme amyloid: evidence for the W64R variant by proteomics in the absence of the wild type protein. Amyloid, 2020, 10.1080/13506129.2020.1720637.
Dumoulin, M., Johnson, R.J.K., Bellotti, V., Dobson, C.M., Human lysozyme. Protein Misfolding, Aggregation, Conform. Dis, 2007, 10.1007/978-0-387-36534-3_14.
Canet, D., Last, A.M., Tito, P., Sunde, M., Spencer, A., Archer, D.B., Redfield, C., Robinson, C.V., Dobson, C.M., Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme. Nat. Struct. Biol., 2002, 10.1038/nsb768.
Dumoulin, M., Last, A.M., Desmyter, A., Decanniere, K., Canet, D., Larsson, G., Spencer, A., Archer, D.B., Sasse, J., Muyldermans, S., Wyns, L., Redfield, C., Matagne, A., Robinson, C.V., Dobson, C.M., A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature, 2003, 10.1038/nature01870.
Dumoulin, M., Canet, D., Last, A.M., Pardon, E., Archer, D.B., Muyldermans, S., Wyns, L., Matagne, A., Robinson, C.V., Redfield, C., Dobson, C.M., Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. J. Mol. Biol., 2005, 10.1016/j.jmb.2004.11.020.
Johnson, R.J.K., Christodoulou, J., Dumoulin, M., Caddy, G.L., Alcocer, M.J.C., Murtagh, G.J., Kumita, J.R., Larsson, G., Robinson, C.V., Archer, D.B., Luisi, B., Dobson, C.M., Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme. J. Mol. Biol., 2005, 10.1016/j.jmb.2005.07.040.
Kumita, J.R., Johnson, R.J.K., Alcocer, M.J.C., Dumoulin, M., Holmqvist, F., McCammon, M.G., Robinson, C.V., Archer, D.B., Dobson, C.M., Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris. FEBS J, 2006, 10.1111/j.1742-4658.2005.05099.x.
Pace, C.N., Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol., 1986, 10.1016/0076-6879(86)31045-0.
Dumoulin, M., Conrath, K., Van Meirhaeghe, A., Meersman, F., Heremans, K., Frenken, L.G.J., Muyldermans, S., Wyns, L., Matagne, A., Single-domain antibody fragments with high conformational stability. Protein Sci., 2009, 10.1110/ps.34602.
El Hajjaji, H., Dumoulin, M., Matagne, A., Colau, D., Roos, G., Messens, J., Collet, J.F., The zinc center influences the redox and thermodynamic properties of Escherichia coli thioredoxin 2. J. Mol. Biol., 2009, 10.1016/j.jmb.2008.11.046.
Kabsch, W., XDS. Acta Crystallogr. Sect. D. 66 (2010), 125–132, 10.1107/S0907444909047337.
Harata, K., Abe, Y., Muraki, M., Full-matrix least-squares refinement of lysozymes and analysis of anisotropic thermal motion. Proteins Struct. Funct. Genet., 1998, 10.1002/(SICI)1097-0134(19980215)30:3<232::AID-PROT3>3.0.CO;2-M.
Afonine, P.V., Grosse-Kunstleve, R.W., Echols, N., Headd, J.J., Moriarty, N.W., Mustyakimov, M., Terwilliger, T.C., Urzhumtsev, A., Zwart, P.H., Adams, P.D., Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr. Sect. D Biol. Crystallogr., 2012, 10.1107/S0907444912001308.
Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Dobson, C.M., Radford, S.E., Blake, C.C.F., Pepys, M.B., Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature, 1997, 10.1038/385787a0.
Moens, P.D.J., Helms, M.K., Jameson, D.M., Detection of tryptophan to tryptophan energy transfer in proteins. Protein J., 2004, 10.1023/B:JOPC.0000016261.97474.2e.
Venyaminov, S.Y., Yang, J.T., Determination of protein secondary structure. Circ. Dichroism Conform. Anal. Biomol, 1996, 69–108, 10.1007/978-1-4757-2508-7_3.
Hagan, C.L., Johnson, R.J.K., Dhulesia, A., Dumoulin, M., Dumont, J., De Genst, E., Christodoulou, J., Robinson, C.V., Dobson, C.M., Kumita, J.R., A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis. Protein Eng. Des. Sel., 2010, 10.1093/protein/gzq023.
Takano, K., Funahashi, J., Yutani, K., The stability and folding process of amyloidogenic mutant human lysozymes. Eur. J. Biochem., 2001, 10.1046/j.1432-1327.2001.01863.x.
Esposito, G., Garcia, J., Mangione, P., Giorgetti, S., Corazza, A., Viglino, P., Chiti, F., Andreola, A., Dumy, P., Booth, D., Hawkins, P.N., Bellotti, V., Structural and folding dynamic properties of the T70N variant of human lysozyme. J. Biol. Chem., 2003, 10.1074/jbc.M211000200.
Polverino de Laureto, P., Frare, E., Gottardo, R., van Dael, H., Fontana, A., Partly folded states of members of the lysozyme/lactalbumin superfamily: a comparative study by circular dichroism spectroscopy and limited proteolysis. Protein Sci., 2009, 10.1110/ps.0205802.
Ahn, M., Hagan, C.L., Bernardo-Gancedo, A., De Genst, E., Newby, F.N., Christodoulou, J., Dhulesia, A., Dumoulin, M., Robinson, C.V., Dobson, C.M., Kumita, J.R., The significance of the location of mutations for the native-state dynamics of human lysozyme. Biophys. J., 2016, 10.1016/j.bpj.2016.10.028.
Chiti, F., Dobson, C.M., Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem., 2017, 10.1146/annurev-biochem-061516-045115.
Ahn, M., Waudby, C.A., Bernardo-Gancedo, A., De Genst, E., Dhulesia, A., Salvatella, X., Christodoulou, J., Dobson, C.M., Kumita, J.R., Application of lysine-specific labeling to detect transient interactions present during human lysozyme amyloid fibril formation. Sci. Rep., 2017, 10.1038/s41598-017-14739-5.
Pain, C., Dumont, J., Dumoulin, M., Camelid single-domain antibody fragments: uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena. Biochimie, 2015, 10.1016/j.biochi.2015.01.012.
Chan, P.H., Pardon, E., Menzer, L., De Genst, E., Kumita, J.R., Christodoulou, J., Saerens, D., Brans, A., Bouillenne, F., Archer, D.B., Robinson, C.V., Muyldermans, S., Matagne, A., Redfield, C., Wyns, L., Dobson, C.M., Dumoulin, M., Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. Biochemistry, 2008, 10.1021/bi8005797.
